{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:21:51Z","timestamp":1782955311638,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T00:00:00Z","timestamp":1549584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s12012-019-09509-w","type":"journal-article","created":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T06:17:16Z","timestamp":1549606636000},"page":"412-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Characterization of microminipig as a laboratory animal for safety pharmacology study by analyzing fluvoxamine-induced cardiovascular and dermatological adverse reactions"],"prefix":"10.1007","volume":"19","author":[{"given":"Yoichi","family":"Tanikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihoko","family":"Hagiwara-Nagasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Kambayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Kitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Hoshiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Izumi-Nakaseko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiko T.","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,8]]},"reference":[{"issue":"Suppl 1","key":"9509_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/00004850-199403001-00004","volume":"9","author":"J Hyttel","year":"1994","unstructured":"Hyttel, J. (1994). Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). International Clinical Psychopharmacology, 9(Suppl 1), 19\u201326.","journal-title":"International Clinical Psychopharmacology"},{"key":"9509_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2131\/jts.40.33","volume":"40","author":"Y Yamazaki-Hashimoto","year":"2015","unstructured":"Yamazaki-Hashimoto, Y., Nakamura, Y., Ohara, H., Cao, X., Kitahara, K., Izumi-Nakaseko, H., et al. (2015). Fluvoxamine by itself has potential to directly induce long QT syndrome at supra-therapeutic concentrations. The Journal of Toxicological Sciences, 40, 33\u201342.","journal-title":"The Journal of Toxicological Sciences"},{"key":"9509_CR3","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/sj.bjp.0705335","volume":"139","author":"JT Milnes","year":"2003","unstructured":"Milnes, J. T., Crociani, O., Archangeli, A., Hancox, J. C., & Witchel, H. J. (2003). Blockade of HERG potassium currents by fluvoxamine: Incomplete attenuation by 6 mutations at F656 or Y652. British Journal of Pharmacology, 139, 887\u2013898.","journal-title":"British Journal of Pharmacology"},{"key":"9509_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/europace\/eup332","volume":"12","author":"G Stirnimann","year":"2010","unstructured":"Stirnimann, G., Petitprez, S., Abriel, H., & Schwick, N. G. (2010). Brugada syndrome ECG provoked by the selective serotonin reuptake inhibitor fluvoxamine. Europace, 12, 282\u2013283.","journal-title":"Europace"},{"key":"9509_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bbr.2013.08.045","volume":"256","author":"R Haberzettl","year":"2013","unstructured":"Haberzettl, R., Bert, B., Fink, H., & Fox, M. A. (2013). Animal models of the serotonin syndrome: A systematic review. Behavioural Brain Research, 256, 328\u2013345.","journal-title":"Behavioural Brain Research"},{"key":"9509_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1254\/jphs.10R16FM","volume":"115","author":"N Kaneko","year":"2011","unstructured":"Kaneko, N., Itoh, K., Sugiyama, A., & Izumi, Y. (2011). Microminipig, a non-rodent experimental animal optimized for life science research: Preface. Journal of Pharmacological Sciences, 115, 112\u2013114.","journal-title":"Journal of Pharmacological Sciences"},{"key":"9509_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jphs.2017.02.002","volume":"133","author":"S Matsukura","year":"2017","unstructured":"Matsukura, S., Nakamura, Y., Cao, X., Wada, T., Izumi-Nakaseko, H., Ando, K., et al. (2017). Characterization of microminipigs as an in vivo experimental model for cardiac safety pharmacology. Journal of Pharmacological Sciences, 133, 103\u2013109.","journal-title":"Journal of Pharmacological Sciences"},{"key":"9509_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2131\/jts.42.93","volume":"42","author":"H Yokoyama","year":"2017","unstructured":"Yokoyama, H., Nakamura, Y., Saito, H., Nagayama, Y., Hoshiai, K., Wada, T., et al. (2017). Pharmacological characterization of microminipig as a model to assess the drug-induced cardiovascular responses for non-clinical toxicity and\/or safety pharmacology studies. The Journal of Toxicological Sciences, 42, 93\u2013101.","journal-title":"The Journal of Toxicological Sciences"},{"key":"9509_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/bcpt.12838","volume":"121","author":"X Cao","year":"2017","unstructured":"Cao, X., Wada, T., Nakamura, Y., Matsukura, S., Izumi-Nakaseko, H., Ando, K., et al. (2017). Sensitivity and reliability of halothane-anaesthetized microminipigs to assess risk for drug-induced long QT syndrome. Basic & Clinical Pharmacology & Toxicology, 121, 465\u2013470.","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"9509_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jphs.2018.01.002","volume":"136","author":"K Ando","year":"2018","unstructured":"Ando, K., Takahara, A., Nakamura, Y., Wada, T., Chiba, K., Goto, A., et al. (2018). Changes of electrocardiogram and hemodynamics in response to dipyridamole: In vivo comparative analyses using anesthetized beagle dogs and microminipigs. Journal of Pharmacological Sciences, 136, 86\u201392.","journal-title":"Journal of Pharmacological Sciences"},{"key":"9509_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2131\/jts.43.507","volume":"43","author":"NJ Lubna","year":"2018","unstructured":"Lubna, N. J., Nakamura, Y., Hagiwara-Nagasawa, M., Goto, A., Chiba, K., Kitta, K., et al. (2018). Electropharmacological characterization of microminipigs as a laboratory animal using anti-influenza virus drug oseltamivir. The Journal of Toxicological Sciences, 43, 507\u2013512.","journal-title":"The Journal of Toxicological Sciences"},{"key":"9509_CR12","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1253\/circj.CJ-16-1106","volume":"81","author":"T Wada","year":"2017","unstructured":"Wada, T., Ohara, H., Nakamura, Y., Cao, X., Izumi-Nakaseko, H., Ando, K., et al. (2017). Efficacy of precordial percussion pacing assessed in a cardiac standstill microminipig model. Circulation Journal, 81, 1137\u20131143.","journal-title":"Circulation Journal"},{"key":"9509_CR13","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/bjp.2008.240","volume":"154","author":"A Sugiyama","year":"2008","unstructured":"Sugiyama, A. (2008). Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts. British Journal of Pharmacology, 154, 1528\u20131537.","journal-title":"British Journal of Pharmacology"},{"key":"9509_CR14","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.16br01966","author":"OG Deardorff","year":"2016","unstructured":"Deardorff, O. G., Khan, T., Kulkarni, G., Doisy, R., & Loehr, C. (2016). Serotonin syndrome: Prophylactic treatment with cyproheptadine. The Primary Care Companion for CNS Disorders. https:\/\/doi.org\/10.4088\/PCC.16br01966 .","journal-title":"The Primary Care Companion for CNS Disorders"},{"key":"9509_CR15","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1056\/NEJMra041867","volume":"352","author":"EW Boyer","year":"2005","unstructured":"Boyer, E. W., & Shannon, M. (2005). The serotonin syndrome. New England Journal of Medicine, 352, 1112\u20131120.","journal-title":"New England Journal of Medicine"},{"key":"9509_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0736-4679(98)00057-2","volume":"16","author":"A Graudins","year":"1998","unstructured":"Graudins, A., Stearman, A., & Chan, B. (1998). Treatment of the serotonin syndrome with cyproheptadine. The Journal of Emergency Medicine, 16, 615\u2013619.","journal-title":"The Journal of Emergency Medicine"},{"key":"9509_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1254\/jphs.13159FP","volume":"124","author":"K Kobayashi","year":"2014","unstructured":"Kobayashi, K., Omuro, N., & Takahara, A. (2014). The conventional antihistamine drug cyproheptadine lacks QT-interval-prolonging action in halothane-anesthetized guinea pigs: Comparison with hydroxyzine. Journal of Pharmacological Sciences, 124, 92\u201398.","journal-title":"Journal of Pharmacological Sciences"},{"key":"9509_CR18","first-page":"277","volume-title":"Basic & clinical pharmacology","author":"BG Katzung","year":"2018","unstructured":"Katzung, B. G.. Histamine (2018). Serotonin, & the Ergot Alkaloids. In B. G. Katzung (Ed.), Basic & clinical pharmacology (14th\u00a0edn., pp.\u00a0277\u2013299). New York: McGraw Hill Education.","edition":"14"},{"key":"9509_CR19","first-page":"532","volume-title":"Basic & clinical pharmacology","author":"C DeBattista","year":"2018","unstructured":"DeBattista, C. (2018). Antidepressant Agents. In B. G. Katzung (Ed.), Basic & clinical pharmacology (14th\u00a0edn., pp.\u00a0532\u2013552). New York: McGraw Hill Education.","edition":"14"},{"key":"9509_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.0954-6820.1920.tb18266.x","volume":"53","author":"LS Fridericia","year":"1920","unstructured":"Fridericia, L. S. (1920). Die sytolendauer in elektrokardiogramm bei normalen menschen und bei herzkranken. Acta Medica Scandinavica, 53, 469\u2013486.","journal-title":"Acta Medica Scandinavica"},{"key":"9509_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair, A. B., & Jacob, S. (2016). A simple practice guide for dose conversion between animals and human. Journal of Basic and Clinical Pharmacy, 7, 27\u201331.","journal-title":"Journal of Basic and Clinical Pharmacy"},{"key":"9509_CR22","first-page":"441","volume":"21","author":"J Ishigooka","year":"1993","unstructured":"Ishigooka, J., Wakatabe, H., Shimada, E., Suzuki, M., Fukuyama, Y., & Murasaki, M., et al. (1993). Phase I trial on the serotonin reuptake inhibitor SME3110 (fluvoxamine maleate). Clinical Evaluation, 21, 441\u2013490.","journal-title":"Clinical Evaluation"},{"key":"9509_CR23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2460\/ajvr.1998.59.01.79","volume":"59","author":"CR Norris","year":"1998","unstructured":"Norris, C. R., Boothe, D. M., Esparza, T., Gray, C., & Ragsdale, M. (1998). Disposition of cyproheptadine in cats after intravenous or oral administration of a single dose. American Journal of Veterinary Research, 59, 79\u201381.","journal-title":"American Journal of Veterinary Research"},{"key":"9509_CR24","first-page":"637","volume":"23","author":"N Sato","year":"1995","unstructured":"Sato, N., Takata, H., Tsukui, M., Tatebayashi, T., Fuji, K., Hiranuma, T., et al. (1995). Studies on the pharmacokinetics of fluvoxamine maleate: Plasma concentration profile and brain distribution in rats. Japanese Pharmacology Therapy, 23, 637\u2013643.","journal-title":"Japanese Pharmacology Therapy"},{"key":"9509_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/00498250600718464","volume":"37","author":"M Miura","year":"2007","unstructured":"Miura, M., & Ohkubo, T. (2007). Identification of human cytochrome P450 enzymes involved in the major metabolic pathway of fluvoxamine. Xenobiotica, 37, 169\u2013179.","journal-title":"Xenobiotica"},{"key":"9509_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2133\/dmpk.24.404","volume":"24","author":"N Murayama","year":"2009","unstructured":"Murayama, N., Kaneko, N., Horiuchi, K., Ohyama, K., Shimizu, M., Ito, K., et al. (2009). Cytochrome P450-dependent drug oxidation activity of liver microsomes from Microminipigs, a possible new animal model for humans in non-clinical studies. Drug Metabolism and Pharmacokinetics, 24, 404\u2013408.","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"9509_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1254\/jjp.66.303","volume":"66","author":"A Sugiyama","year":"1994","unstructured":"Sugiyama, A., Motomura, S., & Hashimoto, K. (1994). Utilization of isolated, blood-perfused canine papillary muscle preparation as a model to assess efficacy and adversity of class I antiarrhythmic drugs. The Japanese Journal of Pharmacology, 66, 303\u2013316.","journal-title":"The Japanese Journal of Pharmacology"},{"key":"9509_CR28","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/bja\/30.9.398","volume":"30","author":"M Mcgregor","year":"1958","unstructured":"Mcgregor, M., Davenport, H. T., Jegier, W., Sekelj, P., Gibbons, J. E., & Demers, P. P. (1958). The cardiovascular effects of halothane in normal children. British Journal of Anaesthesia, 30, 398\u2013408.","journal-title":"British Journal of Anaesthesia"},{"key":"9509_CR29","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/bja\/71.5.696","volume":"71","author":"MS Mckinney","year":"1993","unstructured":"Mckinney, M. S., Fee, J. P. H., & Clarke, R. S. J. (1993). Cardiovascular effects of isoflurane and halothane in young and elderly adult patients. British Journal of Anaesthesia, 71, 696\u2013701.","journal-title":"British Journal of Anaesthesia"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-019-09509-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-019-09509-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-019-09509-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T17:04:36Z","timestamp":1720976676000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-019-09509-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,8]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["9509"],"URL":"https:\/\/doi.org\/10.1007\/s12012-019-09509-w","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,8]]},"assertion":[{"value":"8 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors indicated no potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experiments were approved by the Toho University Animal Care and User Committee (No. 15-52-275, 16-53-275, 17-54-275, 18-51-394) and performed in accordance with the Guidelines for the Care and Use of Laboratory Animals of Toho University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}